世界の低分子CXO市場予測2023-2029:CRO、CMC、CDMO、CMO

【英語タイトル】Small Molecule CXO Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2224)・商品コード:MMG23FB2224
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:104
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥721,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の低分子CXO市場規模と予測を収録しています。・世界の低分子CXO市場:売上、2018年-2023年、2024年-2029年
・世界の低分子CXO市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の低分子CXO市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CRO」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

低分子CXOのグローバル主要企業は、IQVIA、Labcorp、PPD、Wuxi Apptec、PharmaBlock、Asym Chemical、Jiuzhou Pharmaceutical、Pharmaron Beijing、Porton Pharma、ChemPartner、Tigermed、Shanghai Medicilon、VIVA Biotech Holdings、Chengdu Hitgen、Nanjing Genscript、ICON plc、PRA Health、Syneos Healthなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、低分子CXOのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の低分子CXO市場:タイプ別、2018年-2023年、2024年-2029年
世界の低分子CXO市場:タイプ別市場シェア、2022年
・CRO、CMC、CDMO、CMO

世界の低分子CXO市場:用途別、2018年-2023年、2024年-2029年
世界の低分子CXO市場:用途別市場シェア、2022年
・医薬品、バイオ医薬品

世界の低分子CXO市場:地域・国別、2018年-2023年、2024年-2029年
世界の低分子CXO市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における低分子CXOのグローバル売上、2018年-2023年
・主要企業における低分子CXOのグローバル売上シェア、2022年
・主要企業における低分子CXOのグローバル販売量、2018年-2023年
・主要企業における低分子CXOのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
IQVIA、Labcorp、PPD、Wuxi Apptec、PharmaBlock、Asym Chemical、Jiuzhou Pharmaceutical、Pharmaron Beijing、Porton Pharma、ChemPartner、Tigermed、Shanghai Medicilon、VIVA Biotech Holdings、Chengdu Hitgen、Nanjing Genscript、ICON plc、PRA Health、Syneos Health

*************************************************************

・調査・分析レポートの概要
低分子CXO市場の定義
市場セグメント
世界の低分子CXO市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の低分子CXO市場規模
世界の低分子CXO市場規模:2022年 VS 2029年
世界の低分子CXO市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの低分子CXOの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の低分子CXO製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:CRO、CMC、CDMO、CMO
低分子CXOのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:医薬品、バイオ医薬品
低分子CXOの用途別グローバル売上・予測

・地域別市場分析
地域別低分子CXO市場規模 2022年と2029年
地域別低分子CXO売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
IQVIA、Labcorp、PPD、Wuxi Apptec、PharmaBlock、Asym Chemical、Jiuzhou Pharmaceutical、Pharmaron Beijing、Porton Pharma、ChemPartner、Tigermed、Shanghai Medicilon、VIVA Biotech Holdings、Chengdu Hitgen、Nanjing Genscript、ICON plc、PRA Health、Syneos Health

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Small Molecule CXO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule CXO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule CXO Overall Market Size
2.1 Global Small Molecule CXO Market Size: 2022 VS 2029
2.2 Global Small Molecule CXO Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule CXO Players in Global Market
3.2 Top Global Small Molecule CXO Companies Ranked by Revenue
3.3 Global Small Molecule CXO Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule CXO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Small Molecule CXO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule CXO Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule CXO Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule CXO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Small Molecule CXO Market Size Markets, 2022 & 2029
4.1.2 CRO
4.1.3 CMC
4.1.4 CDMO
4.1.5 CMO
4.2 By Type – Global Small Molecule CXO Revenue & Forecasts
4.2.1 By Type – Global Small Molecule CXO Revenue, 2018-2023
4.2.2 By Type – Global Small Molecule CXO Revenue, 2024-2029
4.2.3 By Type – Global Small Molecule CXO Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Small Molecule CXO Market Size, 2022 & 2029
5.1.2 Pharmaceutical
5.1.3 Biopharmaceutical
5.2 By Application – Global Small Molecule CXO Revenue & Forecasts
5.2.1 By Application – Global Small Molecule CXO Revenue, 2018-2023
5.2.2 By Application – Global Small Molecule CXO Revenue, 2024-2029
5.2.3 By Application – Global Small Molecule CXO Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Small Molecule CXO Market Size, 2022 & 2029
6.2 By Region – Global Small Molecule CXO Revenue & Forecasts
6.2.1 By Region – Global Small Molecule CXO Revenue, 2018-2023
6.2.2 By Region – Global Small Molecule CXO Revenue, 2024-2029
6.2.3 By Region – Global Small Molecule CXO Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Small Molecule CXO Revenue, 2018-2029
6.3.2 US Small Molecule CXO Market Size, 2018-2029
6.3.3 Canada Small Molecule CXO Market Size, 2018-2029
6.3.4 Mexico Small Molecule CXO Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Small Molecule CXO Revenue, 2018-2029
6.4.2 Germany Small Molecule CXO Market Size, 2018-2029
6.4.3 France Small Molecule CXO Market Size, 2018-2029
6.4.4 U.K. Small Molecule CXO Market Size, 2018-2029
6.4.5 Italy Small Molecule CXO Market Size, 2018-2029
6.4.6 Russia Small Molecule CXO Market Size, 2018-2029
6.4.7 Nordic Countries Small Molecule CXO Market Size, 2018-2029
6.4.8 Benelux Small Molecule CXO Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Small Molecule CXO Revenue, 2018-2029
6.5.2 China Small Molecule CXO Market Size, 2018-2029
6.5.3 Japan Small Molecule CXO Market Size, 2018-2029
6.5.4 South Korea Small Molecule CXO Market Size, 2018-2029
6.5.5 Southeast Asia Small Molecule CXO Market Size, 2018-2029
6.5.6 India Small Molecule CXO Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Small Molecule CXO Revenue, 2018-2029
6.6.2 Brazil Small Molecule CXO Market Size, 2018-2029
6.6.3 Argentina Small Molecule CXO Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Small Molecule CXO Revenue, 2018-2029
6.7.2 Turkey Small Molecule CXO Market Size, 2018-2029
6.7.3 Israel Small Molecule CXO Market Size, 2018-2029
6.7.4 Saudi Arabia Small Molecule CXO Market Size, 2018-2029
6.7.5 UAE Small Molecule CXO Market Size, 2018-2029
7 Small Molecule CXO Companies Profiles
7.1 IQVIA
7.1.1 IQVIA Company Summary
7.1.2 IQVIA Business Overview
7.1.3 IQVIA Small Molecule CXO Major Product Offerings
7.1.4 IQVIA Small Molecule CXO Revenue in Global Market (2018-2023)
7.1.5 IQVIA Key News & Latest Developments
7.2 Labcorp
7.2.1 Labcorp Company Summary
7.2.2 Labcorp Business Overview
7.2.3 Labcorp Small Molecule CXO Major Product Offerings
7.2.4 Labcorp Small Molecule CXO Revenue in Global Market (2018-2023)
7.2.5 Labcorp Key News & Latest Developments
7.3 PPD
7.3.1 PPD Company Summary
7.3.2 PPD Business Overview
7.3.3 PPD Small Molecule CXO Major Product Offerings
7.3.4 PPD Small Molecule CXO Revenue in Global Market (2018-2023)
7.3.5 PPD Key News & Latest Developments
7.4 Wuxi Apptec
7.4.1 Wuxi Apptec Company Summary
7.4.2 Wuxi Apptec Business Overview
7.4.3 Wuxi Apptec Small Molecule CXO Major Product Offerings
7.4.4 Wuxi Apptec Small Molecule CXO Revenue in Global Market (2018-2023)
7.4.5 Wuxi Apptec Key News & Latest Developments
7.5 PharmaBlock
7.5.1 PharmaBlock Company Summary
7.5.2 PharmaBlock Business Overview
7.5.3 PharmaBlock Small Molecule CXO Major Product Offerings
7.5.4 PharmaBlock Small Molecule CXO Revenue in Global Market (2018-2023)
7.5.5 PharmaBlock Key News & Latest Developments
7.6 Asym Chemical
7.6.1 Asym Chemical Company Summary
7.6.2 Asym Chemical Business Overview
7.6.3 Asym Chemical Small Molecule CXO Major Product Offerings
7.6.4 Asym Chemical Small Molecule CXO Revenue in Global Market (2018-2023)
7.6.5 Asym Chemical Key News & Latest Developments
7.7 Jiuzhou Pharmaceutical
7.7.1 Jiuzhou Pharmaceutical Company Summary
7.7.2 Jiuzhou Pharmaceutical Business Overview
7.7.3 Jiuzhou Pharmaceutical Small Molecule CXO Major Product Offerings
7.7.4 Jiuzhou Pharmaceutical Small Molecule CXO Revenue in Global Market (2018-2023)
7.7.5 Jiuzhou Pharmaceutical Key News & Latest Developments
7.8 Pharmaron Beijing
7.8.1 Pharmaron Beijing Company Summary
7.8.2 Pharmaron Beijing Business Overview
7.8.3 Pharmaron Beijing Small Molecule CXO Major Product Offerings
7.8.4 Pharmaron Beijing Small Molecule CXO Revenue in Global Market (2018-2023)
7.8.5 Pharmaron Beijing Key News & Latest Developments
7.9 Porton Pharma
7.9.1 Porton Pharma Company Summary
7.9.2 Porton Pharma Business Overview
7.9.3 Porton Pharma Small Molecule CXO Major Product Offerings
7.9.4 Porton Pharma Small Molecule CXO Revenue in Global Market (2018-2023)
7.9.5 Porton Pharma Key News & Latest Developments
7.10 ChemPartner
7.10.1 ChemPartner Company Summary
7.10.2 ChemPartner Business Overview
7.10.3 ChemPartner Small Molecule CXO Major Product Offerings
7.10.4 ChemPartner Small Molecule CXO Revenue in Global Market (2018-2023)
7.10.5 ChemPartner Key News & Latest Developments
7.11 Tigermed
7.11.1 Tigermed Company Summary
7.11.2 Tigermed Business Overview
7.11.3 Tigermed Small Molecule CXO Major Product Offerings
7.11.4 Tigermed Small Molecule CXO Revenue in Global Market (2018-2023)
7.11.5 Tigermed Key News & Latest Developments
7.12 Shanghai Medicilon
7.12.1 Shanghai Medicilon Company Summary
7.12.2 Shanghai Medicilon Business Overview
7.12.3 Shanghai Medicilon Small Molecule CXO Major Product Offerings
7.12.4 Shanghai Medicilon Small Molecule CXO Revenue in Global Market (2018-2023)
7.12.5 Shanghai Medicilon Key News & Latest Developments
7.13 VIVA Biotech Holdings
7.13.1 VIVA Biotech Holdings Company Summary
7.13.2 VIVA Biotech Holdings Business Overview
7.13.3 VIVA Biotech Holdings Small Molecule CXO Major Product Offerings
7.13.4 VIVA Biotech Holdings Small Molecule CXO Revenue in Global Market (2018-2023)
7.13.5 VIVA Biotech Holdings Key News & Latest Developments
7.14 Chengdu Hitgen
7.14.1 Chengdu Hitgen Company Summary
7.14.2 Chengdu Hitgen Business Overview
7.14.3 Chengdu Hitgen Small Molecule CXO Major Product Offerings
7.14.4 Chengdu Hitgen Small Molecule CXO Revenue in Global Market (2018-2023)
7.14.5 Chengdu Hitgen Key News & Latest Developments
7.15 Nanjing Genscript
7.15.1 Nanjing Genscript Company Summary
7.15.2 Nanjing Genscript Business Overview
7.15.3 Nanjing Genscript Small Molecule CXO Major Product Offerings
7.15.4 Nanjing Genscript Small Molecule CXO Revenue in Global Market (2018-2023)
7.15.5 Nanjing Genscript Key News & Latest Developments
7.16 ICON plc
7.16.1 ICON plc Company Summary
7.16.2 ICON plc Business Overview
7.16.3 ICON plc Small Molecule CXO Major Product Offerings
7.16.4 ICON plc Small Molecule CXO Revenue in Global Market (2018-2023)
7.16.5 ICON plc Key News & Latest Developments
7.17 PRA Health
7.17.1 PRA Health Company Summary
7.17.2 PRA Health Business Overview
7.17.3 PRA Health Small Molecule CXO Major Product Offerings
7.17.4 PRA Health Small Molecule CXO Revenue in Global Market (2018-2023)
7.17.5 PRA Health Key News & Latest Developments
7.18 Syneos Health
7.18.1 Syneos Health Company Summary
7.18.2 Syneos Health Business Overview
7.18.3 Syneos Health Small Molecule CXO Major Product Offerings
7.18.4 Syneos Health Small Molecule CXO Revenue in Global Market (2018-2023)
7.18.5 Syneos Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Small Molecule CXO Market Opportunities & Trends in Global Market
Table 2. Small Molecule CXO Market Drivers in Global Market
Table 3. Small Molecule CXO Market Restraints in Global Market
Table 4. Key Players of Small Molecule CXO in Global Market
Table 5. Top Small Molecule CXO Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Small Molecule CXO Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Small Molecule CXO Revenue Share by Companies, 2018-2023
Table 8. Global Companies Small Molecule CXO Product Type
Table 9. List of Global Tier 1 Small Molecule CXO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Molecule CXO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Small Molecule CXO Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Small Molecule CXO Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Small Molecule CXO Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Small Molecule CXO Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Small Molecule CXO Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Small Molecule CXO Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Small Molecule CXO Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Small Molecule CXO Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Small Molecule CXO Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Small Molecule CXO Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Small Molecule CXO Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Small Molecule CXO Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Small Molecule CXO Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Small Molecule CXO Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Small Molecule CXO Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Small Molecule CXO Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Small Molecule CXO Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Small Molecule CXO Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Small Molecule CXO Revenue, (US$, Mn), 2024-2029
Table 30. IQVIA Company Summary
Table 31. IQVIA Small Molecule CXO Product Offerings
Table 32. IQVIA Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 33. IQVIA Key News & Latest Developments
Table 34. Labcorp Company Summary
Table 35. Labcorp Small Molecule CXO Product Offerings
Table 36. Labcorp Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 37. Labcorp Key News & Latest Developments
Table 38. PPD Company Summary
Table 39. PPD Small Molecule CXO Product Offerings
Table 40. PPD Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 41. PPD Key News & Latest Developments
Table 42. Wuxi Apptec Company Summary
Table 43. Wuxi Apptec Small Molecule CXO Product Offerings
Table 44. Wuxi Apptec Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 45. Wuxi Apptec Key News & Latest Developments
Table 46. PharmaBlock Company Summary
Table 47. PharmaBlock Small Molecule CXO Product Offerings
Table 48. PharmaBlock Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 49. PharmaBlock Key News & Latest Developments
Table 50. Asym Chemical Company Summary
Table 51. Asym Chemical Small Molecule CXO Product Offerings
Table 52. Asym Chemical Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 53. Asym Chemical Key News & Latest Developments
Table 54. Jiuzhou Pharmaceutical Company Summary
Table 55. Jiuzhou Pharmaceutical Small Molecule CXO Product Offerings
Table 56. Jiuzhou Pharmaceutical Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 57. Jiuzhou Pharmaceutical Key News & Latest Developments
Table 58. Pharmaron Beijing Company Summary
Table 59. Pharmaron Beijing Small Molecule CXO Product Offerings
Table 60. Pharmaron Beijing Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 61. Pharmaron Beijing Key News & Latest Developments
Table 62. Porton Pharma Company Summary
Table 63. Porton Pharma Small Molecule CXO Product Offerings
Table 64. Porton Pharma Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 65. Porton Pharma Key News & Latest Developments
Table 66. ChemPartner Company Summary
Table 67. ChemPartner Small Molecule CXO Product Offerings
Table 68. ChemPartner Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 69. ChemPartner Key News & Latest Developments
Table 70. Tigermed Company Summary
Table 71. Tigermed Small Molecule CXO Product Offerings
Table 72. Tigermed Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 73. Tigermed Key News & Latest Developments
Table 74. Shanghai Medicilon Company Summary
Table 75. Shanghai Medicilon Small Molecule CXO Product Offerings
Table 76. Shanghai Medicilon Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 77. Shanghai Medicilon Key News & Latest Developments
Table 78. VIVA Biotech Holdings Company Summary
Table 79. VIVA Biotech Holdings Small Molecule CXO Product Offerings
Table 80. VIVA Biotech Holdings Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 81. VIVA Biotech Holdings Key News & Latest Developments
Table 82. Chengdu Hitgen Company Summary
Table 83. Chengdu Hitgen Small Molecule CXO Product Offerings
Table 84. Chengdu Hitgen Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 85. Chengdu Hitgen Key News & Latest Developments
Table 86. Nanjing Genscript Company Summary
Table 87. Nanjing Genscript Small Molecule CXO Product Offerings
Table 88. Nanjing Genscript Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 89. Nanjing Genscript Key News & Latest Developments
Table 90. ICON plc Company Summary
Table 91. ICON plc Small Molecule CXO Product Offerings
Table 92. ICON plc Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 93. ICON plc Key News & Latest Developments
Table 94. PRA Health Company Summary
Table 95. PRA Health Small Molecule CXO Product Offerings
Table 96. PRA Health Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 97. PRA Health Key News & Latest Developments
Table 98. Syneos Health Company Summary
Table 99. Syneos Health Small Molecule CXO Product Offerings
Table 100. Syneos Health Small Molecule CXO Revenue (US$, Mn) & (2018-2023)
Table 101. Syneos Health Key News & Latest Developments
List of Figures
Figure 1. Small Molecule CXO Segment by Type in 2022
Figure 2. Small Molecule CXO Segment by Application in 2022
Figure 3. Global Small Molecule CXO Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Small Molecule CXO Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Small Molecule CXO Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Small Molecule CXO Revenue in 2022
Figure 8. By Type - Global Small Molecule CXO Revenue Market Share, 2018-2029
Figure 9. By Application - Global Small Molecule CXO Revenue Market Share, 2018-2029
Figure 10. By Type - Global Small Molecule CXO Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Small Molecule CXO Revenue Market Share, 2018-2029
Figure 12. By Application - Global Small Molecule CXO Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Small Molecule CXO Revenue Market Share, 2018-2029
Figure 14. By Region - Global Small Molecule CXO Revenue Market Share, 2018-2029
Figure 15. By Country - North America Small Molecule CXO Revenue Market Share, 2018-2029
Figure 16. US Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Small Molecule CXO Revenue Market Share, 2018-2029
Figure 20. Germany Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 21. France Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Small Molecule CXO Revenue Market Share, 2018-2029
Figure 28. China Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 32. India Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Small Molecule CXO Revenue Market Share, 2018-2029
Figure 34. Brazil Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Small Molecule CXO Revenue Market Share, 2018-2029
Figure 37. Turkey Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Small Molecule CXO Revenue, (US$, Mn), 2018-2029
Figure 41. IQVIA Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Labcorp Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. PPD Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Wuxi Apptec Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PharmaBlock Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Asym Chemical Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Jiuzhou Pharmaceutical Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pharmaron Beijing Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Porton Pharma Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. ChemPartner Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Tigermed Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Shanghai Medicilon Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. VIVA Biotech Holdings Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Chengdu Hitgen Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Nanjing Genscript Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. ICON plc Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. PRA Health Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Syneos Health Small Molecule CXO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の低分子CXO市場予測2023-2029:CRO、CMC、CDMO、CMO] (コード:MMG23FB2224)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の低分子CXO市場予測2023-2029:CRO、CMC、CDMO、CMO]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆